210 related articles for article (PubMed ID: 16148229)
1. Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Arnon R; Eilam R
J Neurosci; 2005 Sep; 25(36):8217-28. PubMed ID: 16148229
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice.
Aharoni R; Eilam R; Domev H; Labunskay G; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19045-50. PubMed ID: 16365293
[TBL] [Abstract][Full Text] [Related]
3. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
[TBL] [Abstract][Full Text] [Related]
4. Neurogenesis and neuroprotection in the CNS--fundamental elements in the effect of Glatiramer acetate on treatment of autoimmune neurological disorders.
Arnon R; Aharoni R
Mol Neurobiol; 2007 Dec; 36(3):245-53. PubMed ID: 17955199
[TBL] [Abstract][Full Text] [Related]
5. Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Moore S; Khalaj AJ; Patel R; Yoon J; Ichwan D; Hayardeny L; Tiwari-Woodruff SK
J Neurosci Res; 2014 Dec; 92(12):1621-36. PubMed ID: 24989965
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.
Arnon R; Aharoni R
J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
Aharoni R
J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
[TBL] [Abstract][Full Text] [Related]
8. Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis.
Gentile A; Rossi S; Studer V; Motta C; De Chiara V; Musella A; Sepman H; Fresegna D; Musumeci G; Grasselli G; Haji N; Weiss S; Hayardeny L; Mandolesi G; Centonze D
J Neuroimmune Pharmacol; 2013 Jun; 8(3):651-63. PubMed ID: 23370991
[TBL] [Abstract][Full Text] [Related]
9. Mice overexpressing Bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE).
Offen D; Kaye JF; Bernard O; Merims D; Coire CI; Panet H; Melamed E; Ben-Nun A
J Mol Neurosci; 2000 Dec; 15(3):167-76. PubMed ID: 11303781
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
Aharoni R; Eilam R; Lerner S; Shavit-Stein E; Dori A; Chapman J; Arnon R
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948217
[TBL] [Abstract][Full Text] [Related]
11. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
[TBL] [Abstract][Full Text] [Related]
12. Enhanced visualization of axonopathy in EAE using thy1-YFP transgenic mice.
Bannerman PG; Hahn A
J Neurol Sci; 2007 Sep; 260(1-2):23-32. PubMed ID: 17493638
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.
Eilam R; Segal M; Malach R; Sela M; Arnon R; Aharoni R
Glia; 2018 May; 66(5):1098-1117. PubMed ID: 29424049
[TBL] [Abstract][Full Text] [Related]
15. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
[TBL] [Abstract][Full Text] [Related]
16. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
17. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
19. Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.
Gilgun-Sherki Y; Barhum Y; Atlas D; Melamed E; Offen D
J Mol Neurosci; 2005; 27(1):125-35. PubMed ID: 16055951
[TBL] [Abstract][Full Text] [Related]
20. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
